- Home
- SLS vs IH Comparison
SLS vs IH Comparison
Compare SLS & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- IH
- Stock Information
- Founded
- SLS 2012
- IH 1996
- Country
- SLS United States
- IH China
- Employees
- SLS N/A
- IH N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- IH Other Consumer Services
- Sector
- SLS Health Care
- IH Real Estate
- Exchange
- SLS Nasdaq
- IH Nasdaq
- Market Cap
- SLS 75.3M
- IH 85.3M
- IPO Year
- SLS N/A
- IH 2020
- Fundamental
- Price
- SLS $0.90
- IH $1.73
- Analyst Decision
- SLS
- IH
- Analyst Count
- SLS 0
- IH 0
- Target Price
- SLS N/A
- IH N/A
- AVG Volume (30 Days)
- SLS 1.6M
- IH 18.7K
- Earning Date
- SLS 11-13-2024
- IH 12-26-2024
- Dividend Yield
- SLS N/A
- IH N/A
- EPS Growth
- SLS N/A
- IH N/A
- EPS
- SLS N/A
- IH 0.33
- Revenue
- SLS N/A
- IH $132,388,363.00
- Revenue This Year
- SLS N/A
- IH $15.90
- Revenue Next Year
- SLS N/A
- IH $8.64
- P/E Ratio
- SLS N/A
- IH $5.48
- Revenue Growth
- SLS N/A
- IH N/A
- 52 Week Low
- SLS $0.50
- IH $1.47
- 52 Week High
- SLS $1.72
- IH $3.18
- Technical
- Relative Strength Index (RSI)
- SLS 30.01
- IH 56.58
- Support Level
- SLS $0.86
- IH $1.68
- Resistance Level
- SLS $0.98
- IH $1.81
- Average True Range (ATR)
- SLS 0.11
- IH 0.08
- MACD
- SLS -0.02
- IH 0.02
- Stochastic Oscillator
- SLS 21.74
- IH 84.62
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. The majority of iHuman Inc's revenue comes from mainland China.